Full-Spectrum Cannabidiol for Treating Chronic Temporomandibular Arthralgia: A Case Report

Registro completo de metadados
MetadadosDescriçãoIdioma
Autor(es): dc.contributorUniv Nove Julho-
Autor(es): dc.contributorUniversidade Estadual Paulista (UNESP)-
Autor(es): dc.creatorTanganeli, Joao Paulo Colesanti-
Autor(es): dc.creatorTanganeli, Marianna Delle Serre-
Autor(es): dc.creatorOliveira, Daniela Fernandes Lobo Molica-
Autor(es): dc.creatorFernandes, Ellen Eduarda-
Autor(es): dc.creatorRode, Sigmar de Mello-
Data de aceite: dc.date.accessioned2025-08-21T21:29:01Z-
Data de disponibilização: dc.date.available2025-08-21T21:29:01Z-
Data de envio: dc.date.issued2025-04-29-
Data de envio: dc.date.issued2023-07-01-
Fonte completa do material: dc.identifierhttp://dx.doi.org/10.1089/imr.2023.0002-
Fonte completa do material: dc.identifierhttps://hdl.handle.net/11449/303386-
Fonte: dc.identifier.urihttp://educapes.capes.gov.br/handle/11449/303386-
Descrição: dc.descriptionIntroduction: Temporomandibular disorders (TMDs) are public health problem that can considerably affect quality of life. In particular, chronic situations are a challenge for the involved health teams, as they demand care related to central mechanisms and are not always well understood. Since the discovery of the endocannabinoid system and other systems controlled or influenced by it, many studies have reported positive and promising results. Currently, revisions of legislation regarding the use of cannabis and its derivatives in different parts of the world have allowed us to advance scientifically. The treatment of pain using cannabinoid substances can be of great value for the development of drugs that allow significant advancements in the therapy of patients with pain syndromes, particularly in cases of difficult control. Methods: A case of chronic TMD with several previous interventions was presented who was treated with full-spectrum cannabidiol. Treatment period-started December 13, 2021, continuous use. Results: Excellent results and remarkable improvement yielded in the patient's quality of life. Conclusions: Refractory cases can benefit from the use of medicinal cannabis, but further studies are needed to confirm the efficacy and safety of these drugs to long-term treatment.-
Descrição: dc.descriptionUniv Nove Julho, Dept Orafacial Pain, Postgrad Program, Sao Paulo, Brazil-
Descrição: dc.descriptionInst Sci & Technol UNESP, Dept Dent Mat & Prosthodont, Ave Engineer Francisco Jose Longo 777, BR-12245000 Sao Jose Dos Campos, Brazil-
Descrição: dc.descriptionInst Sci & Technol UNESP, Dept Dent Mat & Prosthodont, Sao Jose Dos Campos, Brazil-
Descrição: dc.descriptionInst Sci & Technol UNESP, Dept Dent Mat & Prosthodont, Ave Engineer Francisco Jose Longo 777, BR-12245000 Sao Jose Dos Campos, Brazil-
Descrição: dc.descriptionInst Sci & Technol UNESP, Dept Dent Mat & Prosthodont, Sao Jose Dos Campos, Brazil-
Formato: dc.format60-64-
Idioma: dc.languageen-
Publicador: dc.publisherMary Ann Liebert, Inc-
Relação: dc.relationIntegrative Medicine Reports-
???dc.source???: dc.sourceWeb of Science-
Palavras-chave: dc.subjectCannabis sativa-
Palavras-chave: dc.subjectcannabinoids-
Palavras-chave: dc.subjectendocannabinoids-
Palavras-chave: dc.subjecttemporomandibular disorders-
Palavras-chave: dc.subjectorofacial pain-
Título: dc.titleFull-Spectrum Cannabidiol for Treating Chronic Temporomandibular Arthralgia: A Case Report-
Tipo de arquivo: dc.typelivro digital-
Aparece nas coleções:Repositório Institucional - Unesp

Não existem arquivos associados a este item.